Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Neurol India 70:20312038
Example 5 Arg34GLP-1 (9-37) carries out the modification of terminal amino group: dissolving 1g of Boc-His (Trt) -Aib-OH in 10mL of dichloromethane, adding 0.37g of DCC, cooling to 0 , stirring for 30min, adding 0.22g of HOSu, stirring and reacting at the temperature for 12 hours, filtering, collecting filtrate, and spin-drying the filtrate to obtain a crude Boc-His (Trt) -Aib-OSu product
doi: 10.3389/fneur.2024.1344862 18 BerghoffW
In the QUASAR clinical program, TREMFYA demonstrated high reported rates of endoscopic remission at one year of treatment, continuing to raise the bar for efficacy in the treatment of this inflammatory bowel disease. Johnson and Johnson
It has not yet received FDA approval and is currently available only through medically supervised clinical settings
US$ 24.15
US$ 26.01
US$ 20.06
US$ 22.06
US$ 28.35
US$ 24.01
US$ 26.56
US$ 29.70
US$ 27.04
US$ 20.82
US$ 27.38
US$ 21.70
